Cinnamon Alpha Lipoic Acid

Drug overview for CINNAMON ALPHA LIPOIC ACID (cinnamon bark/chromium picolinate/alpha lipoic acid):

Generic name: CINNAMON BARK/CHROMIUM PICOLINATE/ALPHA LIPOIC ACID
Drug class:
Therapeutic class: Alternative Therapy

No enhanced Introduction information available for this drug.

No enhanced Uses information available for this drug.

DRUG IMAGES

CINNAMON ALPHA LIPOIC ACID CAP

The following indications for CINNAMON ALPHA LIPOIC ACID (cinnamon bark/chromium picolinate/alpha lipoic acid) have been approved by the FDA:

Indications:
None.

Professional Synonyms:
None.

The following drug interaction information is available for CINNAMON ALPHA LIPOIC ACID (cinnamon bark/chromium picolinate/alpha lipoic acid):

Contraindicated
Severe
Moderate

There are 0 contraindications.

There are 0 severe interactions.

There are 1 moderate interactions. The clinician should assess the patient’s characteristics and take action as needed. Actions required for moderate interactions include, but are not limited to, discontinuing one or both agents, adjusting dosage, altering administration.

Drug Interaction	Drug Names
Trientine/Selected Minerals, Oral SEVERITY LEVEL: 3-Moderate Interaction: Assess the risk to the patient and take action as needed. MECHANISM OF ACTION: Mineral supplements may bind to trientine and block its absorption. CLINICAL EFFECTS: The levels and clinical effects of trientine may be decreased. PREDISPOSING FACTORS: None determined. PATIENT MANAGEMENT: The US manufacturer of trientine states that mineral supplements should not be given with trientine. If concomitant therapy is necessary, take trientine on an empty stomach and separate administration at least one hour apart from any other drug. Monitor clinical status for decreased effectiveness and adjust the trientine dose if necessary. DISCUSSION: Multivitamins with minerals may decrease trientine absorption so ensure patient is aware of the risks.	CUVRIOR, SYPRINE, TRIENTINE HCL

Drug Interaction

Drug Names

Trientine/Selected Minerals, Oral

SEVERITY LEVEL: 3-Moderate Interaction: Assess the risk to the patient and take action as needed.

MECHANISM OF ACTION: Mineral supplements may bind to trientine and block its absorption.

CLINICAL EFFECTS: The levels and clinical effects of trientine may be decreased.

PREDISPOSING FACTORS: None determined.

PATIENT MANAGEMENT: The US manufacturer of trientine states that mineral supplements should not be given with trientine. If concomitant therapy is necessary, take trientine on an empty stomach and separate administration at least one hour apart from any other drug. Monitor clinical status for decreased effectiveness and adjust the trientine dose if necessary.

DISCUSSION: Multivitamins with minerals may decrease trientine absorption so ensure patient is aware of the risks.

CUVRIOR, SYPRINE, TRIENTINE HCL

More Frequent	Less Frequent
None.	None.

Rare/Very Rare
Hypoglycemic disorder Insulin autoimmune syndrome

The following precautions are available for CINNAMON ALPHA LIPOIC ACID (cinnamon bark/chromium picolinate/alpha lipoic acid):

Pediatric
Pregnant
Lactation
Geriatric

No enhanced Pediatric Use information available for this drug.

Contraindicated

None

Severe Precaution

None

Management or Monitoring Precaution

None

No enhanced Pregnancy information available for this drug.

No enhanced Lactation information available for this drug.

No enhanced Geriatric Use information available for this drug.